BioWorld Today and partner BioAbility LLC have released BioDefense & Homeland Security 2004: Opportunities for Life Science Companies, a guide to opportunities, programs and procedures in the biodefense industry, with profiles of companies succeeding in the business of biotech.

Thirty-seven success stories are included, ranging from a company that garnered $5.9 million to develop biowarfare detection technology to an emerging firm that secured an NIH grant for $36.1 million to develop an oral smallpox treatment.

There are billions of dollars allocated by the U.S. government to biodefense effforts in 2004. "This represents a great opportunity for biotech and related companies to secure funding for research," said Mark Dibner, editor of the book and president of BioAbility. "Many government agencies are involved and they bring with them a broad range of interests and programs. Everything that you need to start is here."

For more information call 1-800-688-2421 or 1-404-262-5476, or visit www.bioworld.com.